Furthermore, we found that Lrp1 knockdown significantly reduced the levels of FGF2 and phosphorylated ERK compared with NC shRNA treatment in the tracheal tissues of mice with OVA-induced asthma, consistent with our in vitro findings (Figure 10G and Supplemental Figure 5E). The gene discussed is LRP1; the disease is asthma.